Scarica l'app Stockscreener
3.87
0.26%
0.01
Pre-mercato:
3.87
Neuronetics Inc Borsa (STIM) Ultime notizie
Neuronetics’ SWOT analysis: navigating growth in mental health tech stock By Investing.com - Investing.com South Africa
Neuronetics’ SWOT analysis: navigating growth in mental health tech stock - Investing.com
Neuronetics Stock Soars 7.25% on Institutional Investments - AInvest
Major Stakeholder Sells Millions in Neuronetics Stock! - TipRanks
How does Neuronetics Inc. compare to its peersFastest Growing Stock Radar - mustnews.co.kr
Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS - MSN
Can Neuronetics Inc. expand into new markets3x Potential Swing Trade Ideas - mustnews.co.kr
Neuronetics Issues Inducement Equity Awards to New Hires - MSN
Neuronetics Price Target Adjusted Down to $7, Analyst Maintains Buy Rating - AInvest
It's Down 25% But Neuronetics, Inc. (NASDAQ:STIM) Could Be Riskier Than It Looks - 富途牛牛
Neuronetics shares fall 3.42% intraday after granting inducement awards to new employees. - AInvest
Here's What Analysts Are Forecasting For Neuronetics, Inc. (NASDAQ:STIM) After Its Second-Quarter Results - simplywall.st
Neuronetics announces inducement grant - Medical Buyer
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Expands Leadership Team with 31,650 RSU Grants: Major Push in Neurohealth Tech - Stock Titan
Neuronetics (STIM): Canaccord Genuity Adjusts Price Target | STI - GuruFocus
Neuronetics: Canaccord Genuity maintains Buy, PT down to $7 from $8. - AInvest
Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises - MSN
Neuronetics Takes A Leap In Mental Health Tech - Finimize
Neuronetics, Inc. (NASDAQ:STIM) Q2 2025 Earnings Call Transcript - Insider Monkey
Canaccord Genuity lowers Neuronetics stock price target on margin concerns By Investing.com - Investing.com Canada
Canaccord Genuity lowers Neuronetics stock price target on margin concerns - Investing.com
Neuronetics (STIM) Price Target Reduced by Canaccord Analyst - GuruFocus
Neuronetics Reports Q2 2025 Financial Results Surge - The Globe and Mail
Neuronetics: Q2 Earnings Snapshot - Greenwich Time
Neuronetics 2025 Q2 Earnings Beats Expectations as Net Loss Narrows 54.5% - AInvest
Neuronetics Inc (STIM) Q2 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic Shifts - GuruFocus
Neuronetics Inc (STIM) Q2 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic Shifts By GuruFocus - Investing.com Canada
Neuronetics Reports Revenue Growth Amid Greenbrook Acquisition - TipRanks
Neuronetics’ Earnings Call: Revenue Growth Amid Challenges - TipRanks
Neuronetics' 2025 Gross Margin Guidance: A Calculated Path to Profitability Amid Integration Challenges - AInvest
Neuronetics Q2 2025: Navigating Contradictions in Marketing Strategies and Revenue Expectations - AInvest
Earnings call transcript: Neuronetics Q2 2025 Misses EPS Forecast, Stock Drops - Investing.com
Neuronetics Q3 Revenue Forecast $37M-$39M, Close to Consensus Estimate of $38.22M - AInvest
Neuronetics 2025 Financial Forecast: Revenue Ranges from $149M to $155M, Gross Margin at 48%-50% - AInvest
Neuronetics Q3 Revenue Outlook: $37M-$39M vs. Consensus $38.22M - AInvest
Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Neuronetics Reports Second Quarter 2025 Financial and Operating Results | STIM Stock News - GuruFocus
Neuronetics Q2 2025 slides reveal strong revenue growth, path to profitability - Investing.com
Neuronetics Q2 Financial Results: $10.1 Million Loss ReportedNews and Statistics - IndexBox
Neuronetics earnings missed by $0.07, revenue topped estimates - Investing.com
Neuronetics' Q2 2025 Earnings: A Tale of Two Metrics – Revenue Growth vs. Persistent Losses - AInvest
Neuronetics, Inc. SEC 10-Q Report - TradingView
Neuronetics Reports Second Quarter 2025 Financial and Operating Results - The Globe and Mail
Healthcare firm Neuronetics Q2 revenue misses estimates - MarketScreener
Neuronetics Q2 revenue up 18% YoY to $38.1 mln. - AInvest
Neuronetics to Present at the Canaccord Genuity 45th Annual Grow - GuruFocus
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference - The Manila Times
Neuronetics, Inc. CEO Keith Sullivan to Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 - Quiver Quantitative
Neuronetics CEO Showcases Neurohealth Innovation at Major Growth Conference - Stock Titan
What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings - Yahoo Finance
Is Neuronetics Inc. stock overvalued or undervaluedHigh-profit stock alerts - Jammu Links News
What is the risk reward ratio of investing in Neuronetics Inc. stockInvest confidently with actionable market data - Jammu Links News
When is Neuronetics Inc. stock expected to show significant growthGrow your portfolio with growth-oriented stocks - Jammu Links News
How many analysts rate Neuronetics Inc. as a “Buy”Capitalize on high-yield stocks early - Jammu Links News
What analysts say about Neuronetics Inc. stockConsistent high-yield stocks - Jammu Links News
How strong is Neuronetics Inc. company’s balance sheetNavigate the market with precision tools - Jammu Links News
What are analysts’ price targets for Neuronetics Inc. in the next 12 monthsUnprecedented growth rates - Jammu Links News
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):